In 2016, the market sat at $7.2 million. Between 2017 and 2025, Transparency Market Research estimates the market will grow at a compound annual growth rate of 14.9 percent.
Qiagen, F. Hoffman-La Roche, and Illumina lead the expanding market.
Transparency Market Research expects the next-generation sequencing segment to dominate the global personalized health market. It also noted increasing investment toward research and development of biomarkers have already helped propel the industry forward.
More articles on health IT:
Cerner names new leadership for Middle East region
Mount Sinai launches for-profit genomics company
Carnegie Mellon researchers: 5 steps to avoid ransomware
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
